中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

Value of albumin-bilirubin score in predicting the prognosis of patients with liver cirrhosis and esophagogastric variceal bleeding

DOI: 10.3969/j.issn.1001-5256.2021.05.022
  • Received Date: 2020-10-28
  • Accepted Date: 2020-12-04
  • Published Date: 2021-05-20
  •   Objective  To investigate the value of albumin-bilirubin (ALBI) score in evaluating the prognosis of patients with liver cirrhosis and esophagogastric variceal bleeding, and to compare it with Child-Turcotte-Pugh (CTP) score and Model for End-stage Liver Disease combined with serum sodium concentration (MELD-Na) score.  Methods  A retrospective analysis was performed for the clinical data of 155 patients who were diagnosed with liver cirrhosis and esophagogastric variceal bleeding in The First Hospital of Jilin University from August 2018 to April 2019, and according to disease outcome after 1 year of follow-up, these patients were divided into survival group with 98 patients and death group with 57 patients. The influencing factors for prognosis were analyzed, and the value of ALBI score in predicting prognosis was assessed. The t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups; the chi-square test was used for comparison of categorical data between two groups. A Spearman correlation analysis was performed to investigate the correlation between two variables. A multivariate logistic regression analysis was used to investigate independent influencing factors for death within 1 year. The receiver operating characteristic (ROC) curve was plotted, and the area under the ROC curve (AUC) was calculated; the optimal cut-off value was determined based on Youden index. The Z test was used for comparison of AUC between these three scoring systems.  Results  There were significant differences between the survival group and the death group in initial blood loss (U=1994.5, P=0.002), presence or absence of hepatic encephalopathy (χ2=14.154, P < 0.001), severity of ascites (χ2=10.537, P=0.005), total bilirubin (U=1694.0, P < 0.001), albumin (t=-6.633, P < 0.001), aspartate aminotransferase (U=2223.5, P=0.035), Na (U=1859.5, P=0.001), international normalized ratio (U=1259.5, P < 0.001), prothrombin time (U=1331.5, P < 0.001), white blood cell count (U=2008.5, P=0.004), red blood cell count (t=-2.633, P=0.009), red blood cell volume distribution width (U=1719.5, P < 0.001), hemoglobin (U=2150.0, P=0.017), ALBI grade (χ2=48.732, P < 0.001), and CTP class (χ2=34.646, P < 0.001). The death group had a significantly higher ALBI score on admission than the survival group (-1.11±0.59 vs -1.79±0.44, t=7.618, P < 0.001), as well as significantly higher MELD-Na score (18.0[14.5-24.0] vs 12.0[10.0-16.0], U=1176.0, P < 0.001) and CTP score (9.0[8.0-11.0] vs 7.0[6.0-8.0], U=1078.0, P < 0.001). The Spearman correlation analysis showed that ALBI score was positively correlated with CTP score and MELD-Na score (r=0.753 and 0.668, both P < 0.001). The multivariate logistic regression analysis showed that ALBI score (odds ratio [OR]=8.349, 95% confidence interval [CI]: 2.658-26.232), CTP score (OR=1.586, 95%CI: 1.157-2.175), and MELD-Na score (OR=1.188, 95%CI: 1.062-1.328) were independent risk factors for predicting death within 1 year. The optimal cut-off value was -1.485 for ALBI score, 8.5 for CTP score, and 17.5 for MELD-Na score in predicting the 1-year prognosis of patients, with an AUC of 0.818, 0.807, and 0.789, respectively. There was no significant difference between the three scoring systems in predicting the 1-year mortality rate (P > 0.05).  Conclusion  The performance of ALBI score is comparable to that of CTP and MELD-Na scores in predicting the risk of death within 1 year in patients with liver cirrhosis and esophagogastric variceal bleeding, and ALBI score has a good evaluation ability.

     

  • [1]
    Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.

    中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
    [2]
    SASS DA, CHOPRA KB. Portal hypertension and variceal hemorrhage[J]. Med Clin North Am, 2009, 93(4): 837-853, ⅶ-ⅷ. DOI: 10.1016/j.mcna.2009.03.008.
    [3]
    WAN SZ, NIE Y, ZHANG Y, et al. Assessing the prognostic performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin scores in patients with decompensated cirrhosis: A large asian cohort from gastroenterology department[J]. Dis Markers, 2020, 2020: 5193028. DOI: 10.1155/2020/5193028.
    [4]
    KAMATH PS, WIESNER RH, MALINCHOC M, et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology, 2001, 33(2): 464-470. DOI: 10.1053/jhep.2001.22172.
    [5]
    PUGH RN, MURRAY-LYON IM, DAWSON JL, et al. Transection of the oesophagus for bleeding oesophageal varices[J]. Br J Surg, 1973, 60(8): 646-649. DOI: 10.1002/bjs.1800600817.
    [6]
    CREMERS I, RIBEIRO S. Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis[J]. Therap Adv Gastroenterol, 2014, 7(5): 206-216. DOI: 10.1177/1756283X14538688.
    [7]
    D'AMICO G, GARCIA-TSAO G, PAGLIARO L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies[J]. J Hepatol, 2006, 44(1): 217-231. DOI: 10.1016/j.jhep.2005.10.013.
    [8]
    JOHNSON PJ, BERHANE S, KAGEBAYASHI C, et al. Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade[J]. J Clin Oncol, 2015, 33(6): 550-558. DOI: 10.1200/JCO.2014.57.9151.
    [9]
    BIYIK M, UCAR R, SOLAK Y, et al. Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis[J]. Eur J Gastroenterol Hepatol, 2013, 25(4): 435-441. DOI: 10.1097/MEG.0b013e32835c2af3.
    [10]
    MALINCHOC M, KAMATH PS, GORDON FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts[J]. Hepatology, 2000, 31(4): 864-871. DOI: 10.1053/he.2000.5852.
    [11]
    XAVIER SA, VILAS-BOAS R, BOAL CARVALHO P, et al. Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding[J]. Eur J Gastroenterol Hepatol, 2018, 30(6): 652-658. DOI: 10.1097/MEG.0000000000001087.
    [12]
    PORTE RJ, LISMAN T, TRIPODI A, et al. The International Normalized Ratio (INR) in the MELD score: Problems and solutions[J]. Am J Transplant, 2010, 10(6): 1349-1353. DOI: 10.1111/j.1600-6143.2010.03064.x.
    [13]
    KNOX JJ. Addressing the interplay of liver disease and hepatocellular carcinoma on patient survival: The ALBI scoring model[J]. J Clin Oncol, 2015, 33(6): 529-531. DOI: 10.1200/JCO.2014.59.0521.
    [14]
    LEI Q, ZHANG Y, KE C, et al. Value of the albumin-bilirubin score in the evaluation of hepatitis B virus-related acute-on-chronic liver failure, liver cirrhosis, and hepatocellular carcinoma[J]. Exp Ther Med, 2018, 15(3): 3074-3079. DOI: 10.3892/etm.2018.5748.
    [15]
    CHAN AW, CHAN RC, WONG GL, et al. New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score[J]. J Gastroenterol Hepatol, 2015, 30(9): 1391-1396. DOI: 10.1111/jgh.12938.
    [16]
    ZOU D, QI X, ZHU C, et al. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study[J]. Turk J Gastroenterol, 2016, 27(2): 180-186. DOI: 10.5152/tjg.2016.15502.
    [17]
    LU JJ, ZHANG L, DING SG, et al. The prognosis of liver cirrhotic patients with acute esophageal variceal bleeding: A Cox regression analysis[J]. Chin J Dig, 2011, 31(4): 217-220. DOI: 10.3760/cma.j.issn.0254-1432.2011.04.001.

    陆京京, 张莉, 丁士刚, 等. 肝硬化食管静脉曲张破裂出血患者预后Cox回归分析[J]. 中华消化杂志, 2011, 31(4): 217-220. DOI: 10.3760/cma.j.issn.0254-1432.2011.04.001.
    [18]
    CUI S, WANG F, LYU HM, et al. Value of Glasgow-Blatchford score in predicting early prognosis of cirrhotic patients with esophagogastric variceal bleeding[J]. J Clin Hepatol, 2017, 33(10): 1939-1943. DOI: 10.3969/j.issn.1001-5256.2017.10.018.

    崔舒, 王芳, 吕洪敏, 等. Glasgow-Blatchford评分对肝硬化食管胃底静脉曲张破裂出血患者早期预后的预测价值[J]. 临床肝胆病杂志, 2017, 33(10): 1939-1943. DOI: 10.3969/j.issn.1001-5256.2017.10.018.
  • Relative Articles

    [1]Lei WANG, Kangwei LIU, Yuling DUAN, Xinyao LI, Cijun PENG. Current status of the application of robot-assisted laparoscopic hepatectomy[J]. Journal of Clinical Hepatology, 2021, 37(11): 2732-2736. doi: 10.3969/j.issn.1001-5256.2021.11.054
    [2]Zhilong SHI, Hao XU, Changpeng CHAI, Sijie YANG, Wence ZHOU. Clinical application value of difficulty score systems before laparoscopic liver resection[J]. Journal of Clinical Hepatology, 2021, 37(8): 1888-1893. doi: 10.3969/j.issn.1001-5256.2021.08.027
    [3]ZHANG ZhongLin, YUAN YuFeng. Key operating points of laparoscopic hepatectomy for liver tumor in difficult locations[J]. Journal of Clinical Hepatology, 2020, 36(12): 2663-2666. doi: 10.3969/j.issn.1001-5256.2020.12.006
    [4]Gao BenJian, Luo Jia, Liu Ying, Yang XiaoLi, Su Song, Li Bo. Efficacy and safety of laparoscopic versus open liver resection in treatment of colorectal cancer liver metastasis: A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(3): 573-579. doi: 10.3969/j.issn.1001-5256.2020.03.021
    [5]Zhang Bin, Luo De, Peng FangYi, Fang Cheng, Gan Yu, He Kai, Li Bo, Xia XianMing, Su Song. Clinical effect of robot-assisted laparoscopic hepatectomy versus open hepatectomy in treatment of liver diseases:A Meta-analysis[J]. Journal of Clinical Hepatology, 2020, 36(8): 1778-1782. doi: 10.3969/j.issn.1001-5256.2020.08.020
    [6]Li Le, Chen JinMing, Liu ZhongHua, Li Qiang, Shi Ying. Application of enhanced recovery after surgery versus traditional rehabilitation program in hepatectomy: a Meta-analysis[J]. Journal of Clinical Hepatology, 2018, 34(2): 303-308. doi: 10.3969/j.issn.1001-5256.2018.02.017
    [7]Wang XinTuan, Li ShanLin, Geng ZhiMin. A propensity score matching study of laparoscopic and open hepatectomy in treatment of regional hepatolithiasis[J]. Journal of Clinical Hepatology, 2018, 34(3): 531-534. doi: 10.3969/j.issn.1001-5256.2018.03.016
    [8]Han Bing, Ding YiTao, Zhu XinHua, Wu YaFu, Tang Ning, Gao JiaLin, Dai Jun, Xu QingXiang, Cui Heng, He NingNing, Shi XiaoLei. Clinical effect and safety of enhanced recovery after surgery in laparoscopic hepatectomy[J]. Journal of Clinical Hepatology, 2018, 34(3): 567-572. doi: 10.3969/j.issn.1001-5256.2018.03.024
    [9]Tian Zhou, Zhang JianHuai, Sun XiTai, Liu Bin, Qi FuZhen, Wang YeBo, Wu JinSheng, Gu DianHua. Experience in laparoscopic hepatectomy in treatment of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(8): 1712-1716. doi: 10.3969/j.issn.1001-5256.2018.08.024
    [10]Chen Kai, Li XiangNong, Liu Kun, Nan YunGuang, Yang Jun. Clinical effect of hepatectomy versus extracapsular peeling in treatment of hepatic hemangioma[J]. Journal of Clinical Hepatology, 2017, 33(4): 699-704. doi: 10.3969/j.issn.1001-5256.2017.04.020
    [11]Liu Bin, Li WenGang, Chen FuZhen. Laparoscopic hepatectomy: the choice in the era of minimally invasive surgery[J]. Journal of Clinical Hepatology, 2017, 33(4): 643-646. doi: 10.3969/j.issn.1001-5256.2017.04.008
    [12]Wang JinWei, Zhang YaMin. Research advances in methods for determination of tumor boundary in hepatectomy[J]. Journal of Clinical Hepatology, 2016, 32(2): 374-377. doi: 10.3969/j.issn.1001-5256.2016.02.039
    [13]Ma YiYun, Jiang Hua, Zhang HongHeng. Clinical effect of laparoscopic versus open liver resection in treatment of patients with hepatocellular carcinoma complicated by liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(10): 1916-1919. doi: 10.3969/j.issn.1001-5256.2016.10.018
    [14]Xiong Yong, Wang HeBin, Liu DeQin, Chen JianXun, Liu JianPing, Sun ChangQin. Total laparoscopic hepatectomy versus open hepatectomy in treatment of hepatocellular carcinoma in the left lateral lobe: a case- matched analysis[J]. Journal of Clinical Hepatology, 2016, 32(4): 735-738. doi: 10.3969/j.issn.1001-5256.2016.04.026
    [15]Zhang ShengJun, Liu MinLi, Chang Qi, Liu YongFeng. Efficacy comparison of precise and traditional liver resection in treatment of intrahepatic bile duct stones[J]. Journal of Clinical Hepatology, 2015, 31(10): 1648-1651. doi: 10.3969/j.issn.1001-5256.2015.10.022
    [16]Shen YiNan, Huang ShengYu, Hu XianRong, Wang Jie, Yu HongMing, Lu Wen, Lu JunHua, Yang GuangShun, Wu MengChao. Clinical effect of laparoscopic hepatectomy in treating liver metastasis of colon cancer: a systematic review and meta-analysis[J]. Journal of Clinical Hepatology, 2014, 30(12): 1287-1291. doi: 10.3969/j.issn.1001-5256.2014.12.013
    [17]Zhang MingChang, Wang YaZhen, Liu YaHui. Clinical outcomes of partial hepatectomy and management experience in pediatric hepatic cancer patients[J]. Journal of Clinical Hepatology, 2012, 28(12): 915-916+925.
    [18]Jiang Chao, Wang GuangYi, Wang Meng, Zhang Yi. One case report of laparoscopic resection of caudate lobe hepatocellular adenoma[J]. Journal of Clinical Hepatology, 2012, 28(2): 144-145.
    [19]Ou Xi, Xiong Pei, Ye JianYu, Liu JiKui. Application of medical obturation glue in the treatment of hepatolithiasis with laparoscopic hepatectomy[J]. Journal of Clinical Hepatology, 2011, 27(9): 927-930.
  • Cited by

    Periodical cited type(12)

    1. 芦建慧,李勇利,郭瑞芳,薛荣泉. 胆囊切除术后原发性胆总管结石复发患者的临床特征分析. 临床肝胆病杂志. 2025(01): 118-126 . 本站查看
    2. 陈大勇,郭宏志,李权. 腹腔镜胆囊切除术联合同期内镜逆行胰胆管造影术治疗高龄胆囊结石合并继发性胆总管结石患者的效果. 河南医学研究. 2024(06): 1060-1063 .
    3. 仝甲钊,曹振振,孙正路,周从顺,魏书堂. 胆总管结石合并十二指肠乳头旁憩室老年患者ERCP取石成功的影响因素. 河南医学研究. 2024(08): 1358-1362 .
    4. 李梦珂,李渊,王建伟. 胆囊结石合并胆总管多发结石治疗效果及其logistic回归分析. 黑龙江医学. 2024(17): 2054-2057 .
    5. 范嗣琪,魏然,魏杰,李富贵. 乳头夹闭成型+胆总管取石术治疗胆总管结石伴急性胆管炎的应用体会. 腹腔镜外科杂志. 2024(10): 741-746 .
    6. 李泳,周鸿鲲. 不同手术方法治疗胆囊切除后胆总管结石患者的临床疗效分析. 浙江创伤外科. 2023(06): 1118-1120 .
    7. 雷文俤,常贵建,卓信斌,林德新. 胆道冲洗装置在腹腔镜胆总管切开取石术中的应用体会. 腹腔镜外科杂志. 2023(08): 604-608 .
    8. 刘小红,刘洋,武起美. 肾结石行微创手术患者术后复发的影响因素及其防护对策分析. 内蒙古医学杂志. 2023(07): 875-877 .
    9. 吴灵燕,王晓荣,陈柳勇,徐陈柯,黄作斌. 超声联合CT检查在胆总管结石诊断中的应用价值及其漏诊的相关因素分析. 浙江创伤外科. 2023(07): 1372-1374 .
    10. 林秀苹,林洁君,郑艳莉. 彩色多普勒超声术前诊断胆囊结石效能及术后评估结石复发的危险因素分析. 浙江创伤外科. 2023(10): 1954-1957 .
    11. 云逸飞,王林恒,江贵,卢心毓,黄朔,何寅家,张丽杰. 单人经口胆道镜系统直视下与传统X线下非困难性胆总管结石取石的对比研究. 中华消化内镜杂志. 2023(09): 707-712 .
    12. 王亮,陈信浩. 腹腔镜胆囊切除术联合胆总管探查术治疗胆总管结石对患者肝功能及炎性应激反应的影响. 药物生物技术. 2023(06): 614-617 .

    Other cited types(3)

  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 5.8 %FULLTEXT: 5.8 %META: 91.0 %META: 91.0 %PDF: 3.3 %PDF: 3.3 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 6.8 %其他: 6.8 %其他: 0.3 %其他: 0.3 %China: 0.3 %China: 0.3 %India: 0.3 %India: 0.3 %上海: 3.0 %上海: 3.0 %丽水: 0.8 %丽水: 0.8 %北京: 11.0 %北京: 11.0 %南宁: 0.3 %南宁: 0.3 %台州: 0.3 %台州: 0.3 %吉林: 1.0 %吉林: 1.0 %哥伦布: 0.3 %哥伦布: 0.3 %张家口: 3.0 %张家口: 3.0 %徐州: 0.5 %徐州: 0.5 %昆明: 0.3 %昆明: 0.3 %杭州: 0.3 %杭州: 0.3 %武汉: 0.5 %武汉: 0.5 %漳州: 0.3 %漳州: 0.3 %芒廷维尤: 29.8 %芒廷维尤: 29.8 %莫斯科: 2.5 %莫斯科: 2.5 %西宁: 37.3 %西宁: 37.3 %辽阳: 0.3 %辽阳: 0.3 %长春: 1.3 %长春: 1.3 %其他其他ChinaIndia上海丽水北京南宁台州吉林哥伦布张家口徐州昆明杭州武汉漳州芒廷维尤莫斯科西宁辽阳长春

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(3)

    Article Metrics

    Article views (861) PDF downloads(92) Cited by(15)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return